Thomas A MCCOURT
CIK 1478448 · Chief Executive Officer · last filed 2026-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.93M
Companies
3
Total Filings
75
Lifetime Open-Market Net
-$18.49M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 4 of 8
75 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-21 | IRWD | Grant (A) | +60,290 | $0 | EDGAR |
| 2021-12-23 | IRWD | Sell (S) | −46,327 | -$528.6K | EDGAR |
| 2021-11-24 | IRWD | Sell (S) | −52,644 | -$609.6K | EDGAR |
| 2021-11-22 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | −6,044 | $0 | EDGAR |
| 2021-06-09 | IRWD | Grant (A) | +104,690 | $0 | EDGAR |
| 2021-05-26 | IRWD | Sell (S) | −1,716 | -$21.0K | EDGAR |
| 2021-04-21 | ACCELERON PHARMA INC (XLRN) Delisted | Mixed | — | -$589.9K | EDGAR |
| 2021-03-30 | IRWD | Grant (A) | +96,638 | $0 | EDGAR |
| 2021-03-02 | IRWD | Sell (S) | −14,685 | -$133.8K | EDGAR |
| 2021-02-24 | IRWD | Grant (A) | +145,631 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.